- Letter
- Open Access
- Published:
Response to ‘Increase of nerve growth factor levels in the human herniated intervertebral disc: can annular rupture trigger discogenic back pain?’
Arthritis Research & Therapy volume 17, Article number: 106 (2015)
We have read with a great interest the published article by Aoki and colleagues entitled ‘Increase of nerve growth factor levels in the human herniated intervertebral disc: can annular rupture trigger discogenic back pain?’ [1]. The authors suggest that nerve growth factor (NGF) increases in herniated discs, and may play an important role in the generation of discogenic pain. However, we think some points should be discussed.
NGF is a polypeptide that plays an important role for cells belonging to the nervous, endocrine, and immune systems [2]. We think the study group in which the authors evaluated tissue NGF levels is not well defined. Namely, they should state whether the patients have one of following diseases, which could probably affect NGF levels: neuropsychiatric diseases such as epilepsy, depression, schizophrenia, migraine and primary headache; and eating disorders or cardiometabolic diseases such as atherosclerosis, metabolic syndrome and type 2 diabetes mellitus [3]. In addition to these diseases, obesity is also shown to affect NGF levels [4]. In this regard, the above diseases should be taken into account while designing a study group, and the body mass index of participants has to be thought of as another confounding variable and included in multiple regression analysis like age and sex are.
Besides the above confounders, supplements such as vitamin D analogs, zinc, vitamin B12, vitamin A, omega 3 fatty acid or herbal medicines and some drugs such as estrogen, glucocorticoids, acetyl-l-carnitine and antipsychotics also have to be denoted regarding whether the participants use these medications or not because they are affecting factors for NGF [5].
In conclusion, explanation of these concerns will certainly provide clearer information for the readers.
Abbreviations
- NGF:
-
Nerve growth factor.
References
Aoki Y, Nakajima A, Ohtori S, Takahashi H, Watanabe F, Sonobe M, et al. Increase of nerve growth factor levels in the human herniated intervertebral disc: can annular rupture trigger discogenic back pain? Arthritis Res Ther. 2014;16:R159.
Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A. 2001;98:6162–7.
Chaldakov GN, Tonchev AB, Aloe L. NGF and BDNF: from nerves to adipose tissue, from neurokines to metabokines. Riv Psichiatr. 2009;44:79–87.
Bullo M, Peeraully MR, Trayhurn P, Folch J, Salas-Salvado J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. Eur J Endocrinol. 2007;157:303–10.
Lee JC, Pak SC, Lee SH, Lim SC, Bai YH, Jin CS, et al. The effect of herbal medicine on nerve growth factor in estradiol valerate-induced polycystic ovaries in rats. Am J Chin Med. 2003;31:885–95.
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests
The authors declare that they have no competing interests.
See related research by Aoki et al. http://arthritis-research.com/content/16/4/R159 and related letter by Aoki et al., http://dx.doi.org/10.1186/s13075-015-0608-3
Rights and permissions
About this article
Cite this article
Agilli, M., Ekinci, S. Response to ‘Increase of nerve growth factor levels in the human herniated intervertebral disc: can annular rupture trigger discogenic back pain?’. Arthritis Res Ther 17, 106 (2015). https://doi.org/10.1186/s13075-015-0607-4
Published:
DOI: https://doi.org/10.1186/s13075-015-0607-4
Keywords
- Estrogen
- Migraine
- Schizophrenia
- Metabolic Syndrome
- Glucocorticoid